Published in Am J Med on October 01, 2006
Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. JAMA (2014) 3.27
Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia. Am J Med (2011) 1.36
Pneumonia in low and middle income countries: progress and challenges. Thorax (2013) 1.21
Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia. Infection (2010) 1.04
Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study. BMC Health Serv Res (2010) 0.92
Adequacy of an evidence-based treatment guideline for complicated urinary tract infections in the Netherlands and the effectiveness of guideline adherence. Eur J Clin Microbiol Infect Dis (2013) 0.92
Variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study. BMC Health Serv Res (2010) 0.87
Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care (2011) 0.84
Trends in mortality and medical spending in patients hospitalized for community-acquired pneumonia: 1993-2005. Med Care (2010) 0.84
Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporins. Eur J Clin Microbiol Infect Dis (2014) 0.83
Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis. Lung (2013) 0.81
Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia. BMC Med Inform Decis Mak (2016) 0.80
Audit of physicians' adherence to a preprinted order set for community-acquired pneumonia. Can J Hosp Pharm (2010) 0.78
The authors reply. Crit Care Med (2013) 0.75
Severe community-acquired pneumonia and positive urinary antigen test for S. pneumoniae: amoxicillin is associated with a favourable outcome. Eur J Clin Microbiol Infect Dis (2015) 0.75
Association of statin use with cataracts: a propensity score-matched analysis. JAMA Ophthalmol (2013) 5.32
Statins and musculoskeletal conditions, arthropathies, and injuries. JAMA Intern Med (2013) 3.44
Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA (2008) 3.01
Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia. Crit Care Med (2012) 2.38
Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am J Respir Crit Care Med (2011) 2.30
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res (2005) 2.18
A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest (2007) 2.14
Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res (2009) 1.85
Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol (2011) 1.83
Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med (2006) 1.80
Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia. Chest (2012) 1.77
Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis (2012) 1.75
Postoperative complications in the seriously mentally ill: a systematic review of the literature. Ann Surg (2008) 1.69
Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis (2008) 1.62
Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob (2012) 1.55
Severe pandemic H1N1 2009 influenza A infection: are we ready to move on? Respirology (2011) 1.50
Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation. Crit Care Med (2010) 1.42
Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest (2009) 1.40
Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation. J Antimicrob Chemother (2008) 1.37
Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care (2006) 1.33
Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med (2010) 1.26
Outcome of reintubated patients after scheduled extubation. J Crit Care (2011) 1.23
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis (2011) 1.22
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Crit Care (2012) 1.18
Potentially inappropriate prescribing for the elderly: effects of geriatric care at the patient and health care system level. Med Care (2008) 1.13
Incidence of cardiovascular events after hospital admission for pneumonia. Am J Med (2011) 1.10
Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest (2007) 1.09
The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Crit Care (2005) 1.09
In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility. Antimicrob Agents Chemother (2006) 1.06
Mortality after perioperative β-blocker use in noncardiac surgery. JAMA (2013) 1.06
Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation. Pharmacotherapy (2007) 1.05
Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin. Antimicrob Agents Chemother (2007) 1.02
Clinical predictors and risk factors for relapsing Clostridium difficile infection. Am J Med Sci (2010) 1.02
Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis. Pharmacotherapy (2007) 0.99
Antibiotic therapy and 48-hour mortality for patients with pneumonia. Am J Med (2006) 0.99
Pharmacodynamics of intermittent and continuous infusion piperacillin/tazobactam and cefepime against extended-spectrum beta-lactamase-producing organisms. Int J Antimicrob Agents (2005) 0.98
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med (2011) 0.98
The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure. Drugs Aging (2013) 0.96
Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation. J Crit Care (2005) 0.96
Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans. J Am Geriatr Soc (2012) 0.93
Predictors of long-term mortality after severe sepsis in the elderly. Am J Med Sci (2014) 0.92
Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study. BMC Health Serv Res (2010) 0.92
Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther (2010) 0.92
Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med (2013) 0.92
In vitro activity of carbapenems alone and in combination with amikacin against KPC-producing Klebsiella pneumoniae. J Clin Med Res (2011) 0.91
Strategies in the prevention of ventilator-associated pneumonia. Ther Adv Respir Dis (2011) 0.90
Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis. J Infect (2007) 0.90
Community-Acquired Pneumonia Requiring Hospitalization. N Engl J Med (2015) 0.90
Lung transplantation for Williams-Campbell syndrome with a probable familial association. Respir Care (2012) 0.89
Clonal dissemination of Klebsiella pneumoniae carbapenemase KPC-3 in Long Beach, California. J Clin Microbiol (2009) 0.89
Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans. J Med Microbiol (2002) 0.89
Community-acquired pneumonia in elderly patients. Aging health (2009) 0.88
Pulmonary disease among inpatient decedents: Impact of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.88
Association of hypoglycemia with mortality for subjects hospitalized with pneumonia. Am J Med Sci (2010) 0.87
Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications. J Am Geriatr Soc (2010) 0.87
Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clin Infect Dis (2005) 0.87
New-onset epilepsy risk factors in older veterans. J Am Geriatr Soc (2009) 0.86
Pulmonary mucormycosis: what is the best strategy for therapy? Respir Care (2013) 0.86
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases. Clin Ther (2004) 0.86
Impact of obesity on outcomes for patients hospitalised with pneumonia. Eur Respir J (2012) 0.86
Diagnosis of pulmonary malignancy after hospitalization for pneumonia. Am J Med (2010) 0.85
The effect of marital status on the presentation and outcomes of elderly male veterans hospitalized for pneumonia. Chest (2012) 0.85
The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia. BMC Pulm Med (2005) 0.84
Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model. Pharm Res (2006) 0.84
Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia. Chest (2012) 0.84
[Non-pharmacological prevention of ventilator-associated pneumonia]. Arch Bronconeumol (2009) 0.84
Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study. Ann Pharmacother (2013) 0.84
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia. Eur Respir J (2013) 0.84
Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation. Pharmacotherapy (2005) 0.83
Pneumonia: an arrhythmogenic disease? Am J Med (2012) 0.83
In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis. Antimicrob Agents Chemother (2006) 0.83
A clinical pathway for community-acquired pneumonia: an observational cohort study. BMC Infect Dis (2011) 0.82
Impact of prior outpatient antibiotic use on mortality for community acquired pneumonia: a retrospective cohort study. BMC Res Notes (2008) 0.82
Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae. J Clin Med Res (2013) 0.82
Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers. Expert Rev Clin Pharmacol (2012) 0.82
A model for increasing palliative care in the intensive care unit: enhancing interprofessional consultation rates and communication. J Pain Symptom Manage (2011) 0.82
What is the best antimicrobial treatment for severe community-acquired pneumonia (including the role of steroids and statins and other immunomodulatory agents). Infect Dis Clin North Am (2012) 0.81
Mortality and regional oxygen saturation index in septic shock patients: a pilot study. J Trauma (2011) 0.81
Psychologic disorders and statin use: a propensity score-matched analysis. Pharmacotherapy (2013) 0.81
Impact of atypical coverage for patients with community-acquired pneumonia managed on the medical ward: results from the United States Community-Acquired Pneumonia Project. Pharmacotherapy (2003) 0.80
Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease. Clin Ther (2002) 0.80
Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia. Infect Drug Resist (2012) 0.80